Saltar al contenido
Merck

GF85947519

Neodymium

rod, 100mm, diameter 12.5mm, cast, 99%

Sinónimos:

Neodymium, ND007940

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula empírica (notación de Hill):
Nd
Número de CAS:
Peso molecular:
144.24
MDL number:
UNSPSC Code:
12141609
PubChem Substance ID:
NACRES:
NA.23

assay

≥99%

form

rod

manufacturer/tradename

Goodfellow 859-475-19

resistivity

64.0 μΩ-cm, 20°C

bp

3074 °C (lit.)

mp

1021 °C (lit.)

density

7.003 g/mL at 25 °C (lit.)

SMILES string

[Nd]

InChI

1S/Nd

InChI key

QEFYFXOXNSNQGX-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Storage Class

4.1B - Flammable solid hazardous materials

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Franz Fankhauser et al.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 216(6), 381-398 (2003-02-05)
The physical and clinical features of a number of laser energy sources presently being used in plastic and endonasal surgery, such as the Nd:YAG, KTP, Ho:YAG, Er:YAG and CO(2) lasers, are emphasized. Particular attention is paid to the Nd:YAG laser
Francisco J Muñoz-Negrete et al.
BioMed research international, 2015, 742792-742792 (2015-11-12)
Uveitic glaucoma (UG) typically is associated with very high intraocular pressure (IOP) and more intense optic nerve damage than other glaucoma types. This secondary glaucoma requires an early diagnosis and adequate management of both uveitis and glaucoma. It is mandatory
A J Costello et al.
European urology, 35(2), 138-146 (1999-02-06)
Not until 1991 did laser therapy for benign prostatic hyperplasia become a feasible option for the practicing urologist. Prior to the development of side firing free beam laser delivery devices contact Neodymium:YAG, laser therapy for BPH was of limited applicability.
B C Patel et al.
Ophthalmology, 104(7), 1191-1197 (1997-07-01)
Laser-assisted dacryocystorhinostomy (DCR) has failed to match the success rates of external DCR. It has been suggested that this technology may be best suited for revision of failed DCR cases. The authors prospectively evaluated the efficacy of transcanalicular laser-assisted revision
B S Stein
Mayo Clinic proceedings, 73(8), 787-791 (1998-08-14)
Since 1986, benign prostatic hyperplasia has been treated with lasers, but clinical use was not practical until the right-angled fiber was developed in the early 1990s. The neodymium:yttrium-aluminum-garnet (Nd:YAG) laser is one of four types available for treating the prostate.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico